Search Results - U. Platzbecker

Refine Results
  1. 1

    P446: USE OF MIRNA EXPRESSION PATTERNS REVEALS ACTIVIN RECEPTOR 2 PATHWAY IN MEDIATING CHEMO-RESISTANT AML by P. Reichelt, S. Bernhart, F. Wilke, U. Platzbecker, M. Cross, G. Behre

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P1356: PATIENT-SPECIFIC DIGITAL DROPLET PCR ASSAYS FOR MINIMAL RESIDUAL DISEASE DETECTION OF RUNX1 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRAN... by M. Jentzsch, L. Bischof, D. Backhaus, D. Brauer, G.-N. Franke, V. Vucinic, U. Platzbecker, S. Schwind

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P529: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-IN-CLASS CD123-TARGE... by U. Platzbecker, E. Angelucci, P. Montesinos, R. M. Lemoli, A. Spyridonidis, J. Casariego, T. I. Mughal, M. Mohty

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P1313: PREDICTING OUTCOMES IN AML PATIENTS CONSOLIDATED BY AN ALLOGENEIC STEM CELL TRANSPLANTATION USING THE KNOWLEDGE BANK APPROACH by M. Jentzsch, L. Herrmann, L. Bischof, D. Backhaus, D. Brauer, G.-N. Franke, V. Vucinic, U. Platzbecker, S. Schwind

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P724: THE BONE MARROW MESENCHYMAL CELL-DERIVED EXTRACELLULAR MATRIX IS SIGNIFICANTLY ALTERED IN PATIENTS WITH MELODYSPLASTIC SYNDROMES by A. Bains, L. Behrens Wu, M. Richter, V. Magno, S. Rother, M. Cross, C. Werner, M. Wobus, U. Platzbecker

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKE... by C. Craddock, U. Platzbecker, M. Heuser, V. Pullarkat, S. Chaudhury, D. Wu, S. Addo, B. Chyla, Q. Jiang, P. Lee, J. E. Wolff

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    P1381: EARLY FULL DONOR CHIMERISM AFTER FLAMSA RIC BASED ALLOGENEIC HSCT BUT NOT PRESENCE OF MORPHOLOGICAL REMISSION ASSOCIATES WITH OUTCOMES IN R/R AML PATIENTS by J. Ussmann, S. Hell, B. Schetschorke, G. Friedrich, C. Pfrepper, S. Schwind, M. Jentzsch, V. Vucinic, M. Herling, U. Platzbecker, G.-N. Franke

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  8. 8

    P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION by L. Bischof, J. Ussmann, D. Brauer, D. Backhaus, L. Herrmann, G.-N. Franke, V. Vucinic, K. H. Metzeler, U. Platzbecker, S. Schwind, M. Jentzsch

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    P752: TARGETING S100A9 IN THE MYELODYSPLASTIC INFLAMMATORY BONE MARROW MICROENVIRONMENT BY TASQUINIMOD IMPROVES THE SUPPORTIVE FUNCTION OF MESENCHYMAL STROMAL CELLS by M. Wobus, E. Balaian, M. Lissner, R. Towers, U. Oelschlägel, R. Wehner, T. Chavakis, M. Törngren, H. Eriksson, E. Bondesson, U. Platzbecker, M. Bornhäuser, K. Sockel

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML by R. Zinz, C. Rohde, D. Heid, M. Bruckmann, M. Bornhäuser, C. Röllig, U. Platzbecker, C. Baldus, H. Serve, F. Zhou, C. Pabst, C. Müller-Tidow, M. F. Blank

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  11. 11

    P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL by P. Fenaux, V. Santini, R. S. Komrokji, A. Zeidan, G. Garcia-Manero, R. Buckstein, D. Miteva, K. Keeperman, N. Holot, J. Zhang, J. A. Nadal, B. Rosettani, A. Yucel, U. Platzbecker

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  12. 12

    P747: LR-MDS IS CHARACTERIZED BY DIFFERENTIAL EXPRESSION OF INFLAMMASOME-RELATED GENES IN SPECIFIC CELL POPULATIONS by C. Rolfs, M. Schneider, M. Trumpp, L. Fischer, S. Winter, S. Uxa, V. Menger, K. Nenoff, A. S. Kubasch, K. Metzeler, K. Sockel, C. Thiede, L. Hofbauer, A. Brüderle, J. Woo, M. Cross, U. Platzbecker

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  13. 13

    B04 | OVERALL SURVIVAL AND DURATION OF TRANSFUSION INDEPENDENCE FOR FIRST-LINE ERYTHROPOIESIS STIMULATING AGENT-NAIVE PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES TREATED WIT... by V. Santini, M. Della Porta, A. Zeidan, R.S. Komrokji, V. Pozharskaya, S. Rose, K. Keeperman, Y. Lai, S. Kalsekar, B. Aggarwal, D. Miteva, D. Valcárcel, P. Fenaux, J. Shortt, U. Platzbecker, G. Garcia-Manero

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  14. 14

    P416: CLONAL HEMATOPOIESIS IS COMMON IN AML LONG-TERM SURVIVORS AND MAY ASSOCIATE WITH DIABETES AND SECONDARY NEOPLASIAS, BUT NOT OTHER HEALTH OUTCOMES by S. M. Krauß, E. Telzerow, A. S. Moret, D. Richter, M. Rothenberg-Thurley, D. Görlich, M. C. Sauerland, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Enard, W. Hiddemann, K. Spiekermann, U. Platzbecker, K. H. Metzeler

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  15. 15

    C029 | DO APL PATIENTS TREATED WITH ATO+ATRA ACHIEVE A NORMAL LIFE EXPECTANCY? INSIGHTS FROM THE LONG-TERM FOLLOW-UP OF THE GIMEMA APL0406 TRIAL AND THE REAL-LIFE APL0618 STUDY by A. Piciocchi, A. Talone, M. Messina, G. Marsili, V. Sargentini, S. Soddu, L. Cicconi, L. Guarnera, M.D. Divona, P. Musto, F. Ferrara, E. Borlenghi, F. Buccisano, M. Breccia, P. Fazi, A. Venditti, F. Lo Coco, U. Platzbecker, M. Vignetti

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  16. 16

    S287: FACTORS INFLUENCING AUTOLOGOUS LYMPHOCYTE COLLECTIONS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS – THE ROLE OF T-CELL SENESCENCE by V. Vucinic, T. Tumewu, M. Brückner, M. Jentzsch, F. Ramdohr, R. Buhmann, Y. Remane, S. Hoffmann, M. Janz, O. Penack, G. Vogtmann, E. Ruschpler, L. Bullinger, U. Keller, M. Cross, S. Schwind, M. Herling, G.-N. Franke, E. Bach, H. Reinhard, U. Platzbecker

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  17. 17

    C051 | PRELIMINARY EFFICACY AND SAFETY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES IN THE MAXILUS S... by M.G. Della Porta, M.D. Campelo, V. Santini, R. Buckstein, L. Adès, L. Sahagun, G. Das, T. Bryant, T. Zelinsky, Y. Lai, D. Miteva, A. Mcbride, K. Madry, D. Valcarcel, J.M. Torregrosa-Diaz, D. Deeren, S. Grosicki, S. Venugopal, U. Platzbecker, A.M. Zeidan

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  18. 18

    S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INHIBITOR EMAVUSERTIB (CA-4948) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN RELAPSED/REFRACTORY AML O... by G. Garcia-Manero, E. S. Winer, D. J. DeAngelo, S. Tarantolo, D. A. Sallman, J. Dugan, S. Groepper, A. Giagounidis, K. Götze, K. H. Metzeler, C.-C. Li, L. Zhou, E. Martinez, M. Lane, R. von Roemeling, M. Bohme, A. S. Kubasch, A. Verma, U. Platzbecker

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  19. 19

    P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL by L. Oosten, M. van Pel, B. van der Holt, E. Bach, M. Cross, H. Roelofs, P. Meij, B. Wieles, J. J. Zwaginga, A. Lankester, H. Veelken, U. Platzbecker, F. Sanchez-Guijo, M. Algeri, F. Locatelli, T. Devos, J. Cornelissen, D. Niederwieser, W. Fibbe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  20. 20

    P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECI... by K. Geissler, Z. Koristek, T. Bernal del Castillo, J. Novák, G. Rodriguez Macias, S. K. Metzelder, A. Illes, A. Nagy, J. Mayer, M. Arnan, M.-M. Keating, J. Krauter, M. Lunghi, N. Stefano Fracchiolla, U. Platzbecker, V. Santini, Y. Sano, A. Oganesian, H. Keer, M. Lübbert

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: